REPLReplimune Group, Inc.
$13.42+189% 1Y
$13.42
$1.7052 weeks$15.97
Price
+189%1YEnd-of-day closes, not the intraday tick.
RyuScore
Weak, higher than 10% of companiesThe five questions
2 of 5 availableOnly two of the five can be answered for REPL today. The rest need figures this filer has not published. The tabs above still show whatever data does exist.
- Is the business good?not enough filed
- Is it safe?Watch
- Is the price fair?not enough filed
- Is it growing?not enough filed
- What is the market doing?Mixed
P/En/a
Market value$1.08B
1 year+189%
5 years-55%
Charts
As reported to the SEC, without any scoring.
The next results filing is expected around Nov 5, 2026, the same week as a year ago.
What the company said
The company's own words from its current reports to the SEC, newest first
- Sep 16, 2026On September 15, 2026, Replimune Group, Inc. (the “Company”) held its annual meeting of stockholders (the “Annual Meeting”) to consider and vote on the three proposals, each of which is described in greater detail in the Company’s definitive proxy statement on Schedule 14A filed with the U.S. Securities and Exchange …Charter/bylaw amendment or fiscal-year change · Form 8-K
- Aug 14, 2026Reports Fiscal First Quarter 2027 Financial Results and Provides.Earnings release · press release
- Aug 11, 2026On August 9, 2026, the Company entered into an underwriting agreement (the “Underwriting Agreement”) with Leerink Partners LLC, J.P. Morgan Securities LLC, and Cantor Fitzgerald & Co. (each, an “Underwriter” and, collectively, the “Underwriters”), relating to the issuance and sale of an aggregate of 9,701,490 shares …Other event · Form 8-K/A
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.